Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Brighten up the Thursday blues. The sun will come out tomorrow regardless if it rains or not.
Someone today felt the need to off load 64,000 shares with about 10 minutes to go and then someone else picked up 3,000 shares with a minute to the bell. It's the way things work out sometimes.
You have to love how these things play out however but keep in mind the information that has been provided in the last week or so. Not everyday is going to be green because folks see things differently.
I'm still holding and have plans to pick up more next week when my funds clear.
Keeping the faith.
My gut tells me that Q3 isn't going to be all that and a bag of chips.
Latest PR to Shareholders kind of says that if you read carefully.
I could be wrong but the felling is what it is.
Here it is:
SOURCE: Easton Pharmaceuticals, Inc.
October 07, 2014 12:05 ET
Easton Pharmaceuticals Letter to Shareholders
TORONTO, ON--(Marketwired - Oct 7, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH)
Dear Fellow Shareholders,
As you are currently aware Easton pharmaceutical has entered the Medical Marijuana and supporting products market. We would like to thank current investors for their continued support and patience. Management has been developing an update to shed light on the current Health Canada delays which have affected everyone involved in the Canadian Medical marijuana industry and felt that a Letter to Shareholders would be the best method for this update. Health Canada has not issued any new licenses in the last 7 months under the new MMPR system which replaced the outgoing MMAR system, which may be in response to a legal motion set to be heard in February of 2015 in regards to the prior MMAR program. Easton is diligently working to treat the Health Canada industry wide delays as an opportunity rather than a setback.
Our Current Projects Are Outlined As Follows
AMFIL Revenue / Profit Recognition
Easton's ownership in AMFIL's mPact-GROzone Antimicrobial System is our entry into the infrastructure side of the Medical Marijuana industry on a business to business level. It is believed these products provide a clear cost saving benefit to various sized facilities of different industries including the medical marijuana, food and medical facilities. As a business product it also commands a high customized price tag in the range of 100k-150k per unit installed (based on size of area that's being serviced) and maintains quite high margins (over 50%) on initial product sales as well as maintenance contracts that follow initial installation. Residual income from the maintenance contracts will affect both the top and bottom lines. AMFIL is in the midst of completing a financial audit; Easton should be able to recognize meaningful revenues within the 4th quarter as it relates to the installation of GROzone units that AMFIL has currently shipped and installed.
Medical Marijuana Facility (Port Perry Ontario)
Easton owns a binding exclusive option to purchase up to 49% on this facility awaiting a Health Canada national MMPR growers license. This facility has received a letter to build, which is considered to be 1 of only 25 issued. Management believe Health Canada's final approval and a national MMPR growers license is imminent based on the high level to detail in meeting the strict health Canada MMPR guidelines including upgraded security features. This exclusive purchase option agreement requires no additional funds to be forwarded until a final MMPR growers license has been granted by Health Canada. This places all associated carrying costs on the current owners and partners, and results in Easton conserving its cash for use in other projects. The current facility can be expanded with appropriate applications once it has been granted a growers license. Pictures of the facility are available on our website. Address details and the name of the company are unable to be disclosed at this point so not to adversely affect the licensing process with health Canada.
The above listed items addresses all our completed Marijuana related deals and the majority of questions that relate to it. Management has worked hard to avoid any risks associated with the industry while trying to maximize the returns. The following is the direction in which we intend to focus the company to better enhance shareholder value looking forward. This should show the shareholder our commitment to the industry; which we consider to have broader appeal to the consumer. Currently in Canada, Marijuana is allowed to be imported (licensed providers or LP's are allowed to ship marijuana into the country for resale). Marijuana is considered a drug and its production is considered manufacturing. Setting up production in a State that allows for current production through partnerships can speed availability of medication available to patients in Canada.
Ms. Carla Pepe, CEO of Easton Pharmaceuticals, commented: "After watching Junior mining companies come and go in this sector, I am pleased to be directing Easton Pharmaceuticals, whose core transdermal delivery technology, patents can add value to its Medical Marijuana initiatives. This is a historic time for the North American marijuana industry, and I hope to make Easton a positive influence in the exciting cross border sales and marketing of marijuana and related products. It is good to be working with our partner companies who understand the complexities of this industry and how important it is to identify, develop and expand credible business opportunities in this space."
Currently in the United States, 23 states have legalized cannabis for medical use with three more states pending legislation. Washington and Colorado State have legalized marijuana for recreational purposes as well. The legalized marijuana industry in the United States is thriving and local governments are benefiting from the tax revenues generated. Easton believes that there will be broad acceptance in the US market that will in turn have a direct effect on Canadian views towards full legalization. We also note that a major liberal point in their election campaign platform is Marijuana Legalization.
NEW INITIATIVES FOR IMMEDIATE REVENUE GENERATION AND PROFITABILITY
Easton's E-Cigarette,Vaporizer and CBD Directive
This is a new developing field that is directly related to the effective delivery of medicine to patients. A key positive factor we see with vaporizers is the discreetness they offer and elimination of second hand smoke release into the environment. Easton believes they are able to improve on the current vaporizer model employed by current vaporizer and E-cigarette companies. The company has plans to generate revenue immediate through diversification in the medical marijuana field in light of current Health Canada delays though a venture into vaporizers, glassware and CBD e-liquids, including but not limited to, branded products. To expedite this process; Easton is currently in advanced late stage discussions with a current revenue generating and profitable Vaporizer company that will immediately launch products in multiple websites which will also include a comprehensive SEO campaign. The Company has a focus of selling these products online through the Easton website, possible retail outlet, and distribution through contracts. The details on the entry into this and other products will soon follow.
US Marijuana Initiatives
Easton is in current discussions with multiple US grower organizations and have completed the long due diligence process in Colorado, Washington and California. These grow operations ranging from 25k-150k square feet and Easton wish's substantial investments. We plan to provide you the stakeholders with further details on these agreements as soon as they become available.
Ms. Carla Pepe, CEO of Easton Pharmaceuticals, further commented: "I look forward to finalizing these US agreements in a timely fashion with the consideration that there is a lot of due diligence that is usually involved in the time consuming acquisition process. We hope to soon see visionary investors and stakeholders in Easton pharmaceuticals experience positive benefits from the solid foundation we have laid out together."
Canadian Marijuana initiatives
Easton has in the past considered building out its own facility in the Greater Toronto Area but decided against this choice in favor of a pre existing facility that already maintained a letter to build. As the delays from Health Canada towards current "ready for inspection" facilities drag on this gives Easton the unique opportunity to develop its own facility; to grow and market Medical Marijuana as well as obtain ownerships in Canadian facilities at discounted rates. Easton will be able to import excess marijuana from its US initiatives if prices dictate it do so. This process is currently used by Canadian LP Bedrocan who currently ships in Medical Marijuana for sale in Canada from its subsidiaries in Holland.
Ms. Pepe's final thoughts: "More fundamentally, I think long-term proactive thinking will move us forward delighting customers with exceptional high quality products at reasonable prices, which will ultimately earn us more business from customers, including within our new business segments. If we take a long-term view, we anticipate the interests of customers and shareholders will align."
We would like to again thank our shareholders for their continued support. We plan to follow this Shareholder letter with other shareholder letters in a more frequent basis, that will answer most commonly asked business related questions directed to our corporate website or Twitter handle.
Please follow us on Twitter at @EastonPharma
About Easton Pharmaceuticals
Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues geared towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system and the exclusive option to purchase up to 50% in a medical marijuana grow-op business / facility which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.
For More Information Visit:
http://www.eastonpharmaceuticalsinc.com
Safe Harbor
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "hope", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact Information
Contact:
Carla Pepe
Easton Pharmaceuticals Inc.
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
All righty then - we are into day 6 of the Q3 watch.
Just need to know when to make the popcorn.
UNQT setting the world on fire.
I'm thinking nothing but 1's since 9/29.
9/30 - 2,375,000 = $237.50
10/1 - 19,000,000 = $1,900.00
10/2 - 13,000,000 = $1,300.00
10/3 - 3,000,000 = $300.00
10/6 - 2,600,000 = $260.00 so far today
Starting to feel the burn.
Yet only 600,000 shares have traded so far today and we are at an hour into the bell. And they were 1's.
Seems like a made rush to pick up those 2's.
Update: 2 million more shares traded so we are up to 2,600,000 at 1's.
That's the picture I am seeing.
Instead of backing up the truck on 1/27/12 and over loading my account on this POS stock - I should have opened my eyes and sold. At least I could have gotten out at .0064. What a foolish thing to do. Lesson learned.
Just because it looked like a duck and sounded like a duck it was nothing more that a lipstick wearing flying pig.
The only thing good is that it can be written off at the end of the year.
Good Old Tom - You know and I know that NC doesn't take kind to the practices of folks like you. And you call yourself a CEO.
I just got a new follower on my Twitter account.
Called "Cannabuzz Card".
I haven't checked them out yet to see what they are all about but they provided their website if anyone wants to see how they may or may not stack up against SING.
www.cannabuzz.com. They also provided a number 866-209-7350 to call for more information.
Will check them out later but found it interesting none the less.
ST is showing ask at .0131 and the bid at .0140 - both are below yesterdays close.
And this shows "The Market is liking what they see". Really???
If everything that was said in this Money TV spot is fact then Q3 should be a very interesting read when released and Q4 should be a crazy read.
It is interesting however that this news hasn't affected the bid/ask price so far this morning. 120 is a big jump from the 24 we heard about only a few short weeks ago.
Are we starting to see some upward movement here?
16 painted looking for 165
Don't have L2 access - Sorry.
There are others on this board that do. Screen shots would be nice once in while.
It appears that SING is lighting up the world this morning by going backwards. This is nuts.
I predict that we see 3's this week and perhaps 2's will make a visit.
Way to go Good Old Tom.
Ask sitting below Friday's close. Way below. WTF.
Probably not today with an hour and change to go but next week is another thing and I wouldn't doubt it one little bit.
Perhaps someone is tired of the same O same O from Greg and this MoneyTV spot just pushed them over the edge.
Reinitiating coverage is a good sign for Greg with MONEYTV. Don't think he would spend the money if it wasn't.
I don't remember the cost but it ain't cheep. I think it's something like $15,000 for 10 spots - I could be wrong but I know it isn't cheep.
Was nice to hear his voice again and I think we will have some upcoming news sooner than later.
GO SING
JMHO
Point well made. At least we know that he hasn't fallen off the face of the earth and is out there working on something. Perhaps it's time to buy some more.
Out this morning (and above) but not really worth reading.
Union Equity Inc. Announces Shareholder Updates
Date : 09/19/2014 @ 8:00AM
Source : eTeligis
Stock : Union Equity, Inc. (PC) (UNQT)
Quote : 0.0001 0.0 (0.00%) @ 7:17AM
Union Equity Inc. Announces Shareholder Updates
PrintAlert
INDIANAPOLIS, IN (Eteligis Inc.)
INDIANAPOLIS, IN , United States, via ETELIGIS INC., 09/19/2014 - - Union Equity, Inc. (OTC PINK: UNQT), and CEO, JT Thornburg, would like to announce a few shareholder updates. Union Equity is in the process of starting its financial audit. This has been delayed a short amount of time. This delay has been due to wanting to ensure that Union Equity will be able to do the audit and the third quarter financial filings in the same time frame.
Union Equity Inc. is presently engaged with two corporations that have shown great interest in doing business together. Union Equity is taking the time and effort to cover all avenues to ensure what will be best for the company and the shareholders. New details are worked out daily, and Union Equity hopes to bring new updates as they become available.
About Union Equity Inc.
Union Equity, Inc. is a holding company that is comprised of 1 subsidiary that covers a vast business spectrum - Union Equity Investments, Inc.
About Union Equity Investments Inc.
Union Equity Investment, Inc. is to provide the best possible risk-return value for Union Equity shareholders, by making direct investments into or outright purchases of revenue generating foreign and domestic private/public companies, which are in the need of a strong management team and capital in order to make it to the next level.
Contact
To learn more about Union Equity Inc., Please Contact
Investor Relations
Office: (317) 575-4113
Nice and thanks for the posting. Only 12 days away and a perfect time slot.
I also noticed that they are "presentors / speakers" however not "sponcers" so more exposure for SING without having the big overhead costs of sponcership.
Some people get their jollies by putting out BS information when they know from the beginning that it isn't true.
As long as it is about the company it's ok to post regardless of fact or fiction or so it seems.
Good question.
Even in Canada they have to have permits or something. You can't just dig a hole or construct a building where ever you want.
BTW - Not real concerned over the PPS. This can change quickly by someone buying or selling one (1) fricken share.
EAPH is getting beat up again today. OUCH.
BTW EAPH needs a proof reader before PR's are released. The PR that came on 9/15 is showing Dr. Daniel Bag. I thought his name was Bagi? I'm not a perfect speller but you would think they would have gotten his name right.
Thanks. Makes sense now.
It wasn't showing up on any of the others I am holding and only as a partial here. If I searched them individually the PC shows but not consistantly once you go to the message boards.
You are also correct that it should read PC and not just P.
Stupid question because I just noticed it and I don't know.
Singlepoint, Inc. (P (SING)
What's the (P stand for?
Thanks Market Spy. That's what I thought and I also looked there after I posted.
Found nothing there either.
Isn't the filing something that would have to be disclosed on the OTCMarkets.com? If so I see nothing there.
Where else could this information be located?
Having trouble getting my head around a statement.
If everyone knows this is a scam why would 3 hours later that same someone might be interested in purchasing at .0002? Unless there is money to be made by the shareholder on a scam which means that they become part of the scam?
A little inside information to share.
My girlfriend’s brothers cousin said that the pocket puffer is beinging assembled in a secret location and will be ready as a stocking stuffer for Christmas. Not sure where she got this information but please don’t tell my wife as I don’t want her to know about the pocket puffer until I see it.
They can't and probably never will. It's going to be one thing after another...just a stall until they decide to announce that they pulled it all together because of a multitude of issues.
27.3 million so far and it hasn't even been an hour since the bell but the real question is do we see .0003 today or tomorrow?
Almost 25 million showing and guess what - .0004 is also showing.
Good Old Tom - Will the Pocket Puffer come to save the day? Doubt it even exist.
There ya go - a solid .0005 with volume to support it at almost 17 million.
.0004's a coming and it won't be long.
I hate agreeing with certain assessments on this board but the latest PR, to me, seems like what is being called a "fluff" PR.
Really what was said - nothing of substance. Everything is forward looking so why bother putting this out. There is nothing said that will affect Q3 anyways.
What I gathered about the MJ part may in fact be a lot longer getting going than originally lead to believe.
Was surely hoping for some meat.
JMHO
NEWS out just in time for Christmas.
September 15, 2014 08:00 ET
Easton Pharmaceuticals Announces Preparations for North American Product(s) Launch
TORONTO, ON--(Marketwired - Sep 15, 2014) - Easton Pharmaceuticals (OTC: EAPH) Announces it has finalized and prepares for the launch of 3 initial OTC therapeutic products and other additional products for a marketing and sales launch.
As announced, Easton has previously received all required ingredients and has readied 3 of its main OTC therapeutic products which are VIORRA TM, SKIN RENOU HA, and KENESTRIN GEL. The 3 products will be made immediately available once packaging is delivered which involves containers and labeling. Included with the 3 initial Easton products are an additional 3 cosmetic products as a result of an agreement with a Toronto, Canada based manufacturer who will manufacture and supply the U.S. and Canadian markets. The line of products will be formally announced in the next few short weeks which is expected to be in conjunction with a marketing plan and partner who have been in discussions with the company over the past month for U.S. and Canadian distribution. The new marketing partner will be replacing the previous agreement signed with Global Links (OTC: GLCO) following Easton's termination of the agreement originally signed in May of 2014.
The missing packaging and labeling component is only expected to take 2 weeks for completion. Products are expected to be available for sale within the next 30 to 45 days in preparation for the upcoming Christmas buying season on Easton's website as well as multiple distributors as part of a comprehensive marketing strategy. Full details to be made shortly available. The initial products being launched, VIORRA TM, SKIN RENOU HA, and KENESTRIN GEL are expected to command a lucrative minimum gross margin of 40-50% at a wholesale level, which is considered very conservative. Detailed retail pricing will be announced on launch date.
VIORRA ™ = (Will service a broad female market including a growing ageing female population, but can also be utilized by younger woman to assist in naturally treating FSAD and lack of lubricity, a condition affecting millions of women of different ages. )
SKIN RENOU HA = ( A product to service the multi billion dollar anti wrinkle cosmetic industry which utilizes the company's proprietary and patented transdermal delivery matrix to deliver Hyaluronic Acid and other active ingredients to treat wrinkles and ageing. )
KENESTRIN GEL = ( A product to help treat the multi billion dollar Rheumatoid Arthritis industry which affects people of all ages. The products main active ingredient is Hyaluronic Acid which acts as a cushion and lubricant in joints and other tissues which is applied utilizing the company's patented transdermal delivery matrix. )
Easton will continue to utilize BMV Medica for its distribution of the same products in Mexico and Latin American markets and will use products manufactured in Canada for the short term to supply the Mexican and Latin American market until a final agreement is reached with a Mexican manufacturer which Dr. Daniel Bag and BMV has stated is close to finalization.
Carla Pepe, CEO of Easton Pharmaceuticals, commented "Although the launch of Viorra and our other OTC therapeutic products have recently taken a back seat to our medical marijuana initiatives, the company is quickly moving towards the launch of these products to take advantage of the Christmas shopping season and to demonstrate our commitment to this part of our business. We believe our marketing strategy which we expect to disclose very shortly will provide good exposure and resulting sales of all products being launched."
In other developments, Easton reports that its Canadian Medical Marijuana initiative and its exclusive option with its partner regarding a letter to build it has received towards a medical marijuana national growers license is progressing. Two new medical marijuana licenses were recently issued by health Canada as they deal with a backlog and implement new security requirements for licensed producers and company's who have received letters to build. Other news and updates soon expected regarding a possible Canadian dual listing and on its partnership with AMFIL Technologies.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues geared towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system and the exclusive option to purchase up to 50% in a medical marijuana grow-op business / facility which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.
For More Information Visit:
http://www.eastonpharmaceuticalsinc.com
Safe Harbor
This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
Contact Information
Contact:
Carla Pepe
Easton Pharmaceuticals Inc.
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
Time & Sales
Price Size Mkt Time
u $0.0006 9,151,631 OTO 16:17:38
t $0.0062 0 OTO 16:14:35
t $0.0006 21,700,000 OTO 16:14:05
This was the after hours activity. There was over 30 million shares traded.
You will notice that the middle "t" trade above was posted at .0062 which had to be the reason for the showing of the 933% gain. It however was crossed out and no volume was shown.
There was also a "u" trade of 9 million but don't know what a "u" trade is.
Good Old Tom - .0005 ain't that far away.
Looks like Greg's days on Money TV are over. Another week and no show.
Perhaps the companies contract ended with Money TV and he used up all his alloted spots. I know that the company has x number of appearances for a specific dollar amount so perhaps he just didn't renew coverage at this time with them.
Now it looks like we wait for Q3 to come out and see where things are since PR's aren't flowing.
When you need to laugh read the following from Good Old Tom.
Rapid Fire Marketing Issues Letter to Shareholders
August 13, 2014
The Company has issued the following update to shareholders regarding Rapid Fire Marketing’s business going forward for the remainder of 2014 and into 2015:
Topics to be covered:
· Dry Vaporizer
· Business Update including Merger/Acquisitions
PocketPuffer ® Dry Vaporizer
Drawing for the 5 PocketPuffer® Units:
Drawing for the PocketPuffer ® has been completed and winners were notified via email on July 29, 2014. All of the winners responded and are standing by to receive their PocketPuffer® and provide their valuable feedback regarding the unit.
First Production Model
A couple of weeks ago we received our first production model of the PocketPuffer® complete with graphics, branding and logo. During the last 2 weeks, we have conducted extensive testing in-house. While the unit worked very well, we did discover a couple of minor issues with the unit. These issues were discussed with our manufacturer and those updates are being included on the first production run. While this has led to another minor delay in full scale production, we feel that the units we will receive on this first production run will be of high quality and will work very well for users/testers of the unit. The manufacturer will ship units in batches as soon as they are complete. We expect to get an update on the timeline for production and shipping this week.
IMHO - The reason for the extensive delay is that everything had to be translated into 17 different languages and since the space shuttle isn't being used anymore thay have to find another way of getting these Pocket Puffers back to earth.